Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2012
10/10/2012EP2508515A1 Ligands for g-protein coupled receptors
10/10/2012EP2508513A1 2-pyridone compounds
10/10/2012EP2508512A1 Novel N,N'-hydrazino-bis-isatin derivatives with selective activity against multidrug-resistant cancer cells
10/10/2012EP2508511A1 Inhibitors of viral replication, their process of preparation and their therapeutical uses
10/10/2012EP2508510A1 Hydroxyphenyl pyrrole compounds containing an hydroxamic acid as hdac inhibitors and medicinal applications thereof
10/10/2012EP2508503A1 Spiro compounds and pharmaceutical use thereof
10/10/2012EP2508231A2 Imidazoles for treating multi-drug resistant bacterial infections
10/10/2012EP2508204A2 Remedies for diseases caused by vascular contraction or dilation
10/10/2012EP2508190A1 Macrophage phagocytosis-activating composition and/or composition promoting cytokine production in macrophages
10/10/2012EP2508188A1 Pharmaceutical formulations containing dapagliflozin propylene glycol hydrate
10/10/2012EP2508187A1 Triflusal powder containing cyclodextrin as a stabilizing agent
10/10/2012EP2508186A1 Phenoxazinones or phenothiazones as inhibitors of amyloid formation
10/10/2012EP2508185A1 Anti-tumor effect potentiator
10/10/2012EP2508184A1 Pyridopyrazine derivatives and their use
10/10/2012EP2508183A1 Interleukin-1 blocker for use in the treatment of age-related macular degeneration
10/10/2012EP2508182A1 Hydralazine for use in the treatment of age-related macular degeneration
10/10/2012EP2508181A1 Compositions and Methods Of Using (R)-Pramipexole
10/10/2012EP2508180A1 Sn-1(3) Monoacylglycerides and lipid absorption
10/10/2012EP2508179A1 Use of L-Carnitine, salts and derivatives thereof for reducing or preventing fatigue and improving cognitive function
10/10/2012EP2508178A2 Use of nutritional compositions for preventing disorders
10/10/2012EP2508177A1 Combinations comprising 3-phenylsulfonyl-8-piperazinyl-1yl-quinoline
10/10/2012EP2508176A1 Novel combination treatment of cancer
10/10/2012EP2508175A1 Pharmaceutical composition comprising fesoterodine or a salt or a solvate thereof
10/10/2012EP2508174A1 Pharmaceutical composition
10/10/2012EP2508173A1 Stabilized pharmaceutical composition comprising fesoterodine
10/10/2012EP2508172A1 Stable and uniform formulations of entecavir and preparation method thereof
10/10/2012EP2508171A1 Pharmaceutical magnetic nano-particle composition
10/10/2012EP2508170A1 Liposome of irinotecan or its hydrochloride and preparation method thereof
10/10/2012EP2507394A1 Diagnostic and therapeutic methods for corneal ectasia following refractive surgery, keratoconus or pellucid degeneration
10/10/2012EP2507374A2 Novel therapeutic rna interference technology targeted to the pdx-1 oncogene in pdx-1 expressing neuroendocrine tumors
10/10/2012EP2507253A2 6-substituted estradiol derivatives and methods of use
10/10/2012EP2507250A1 Solid state forms of fosamprenavir calcium salt and process for preparation thereof
10/10/2012EP2507249A1 Inhibitors of flaviviridae viruses
10/10/2012EP2507245A2 Multicyclic compounds and methods of use thereof
10/10/2012EP2507244A1 Tricyclopyrazole derivatives
10/10/2012EP2507243A1 Spiroindolinone pyrrolidines
10/10/2012EP2507242A1 Co - crystals of a triazolo [4,5 - d]pyrimidine platelet aggregation inhibitor
10/10/2012EP2507241A1 Methanocarba adenosine derivatives and dendrimer conjugates thereof
10/10/2012EP2507239A1 Azacyclic spiro derivatives
10/10/2012EP2507238A1 Diphenyl-pyrazolopyrdine derivatives, preparation thereof, and use thereof as nuclear receptor not modulators
10/10/2012EP2507237A1 Imidazoquinolines which act via toll - like receptors (tlr)
10/10/2012EP2507236A1 Triazolopyridine derivatives
10/10/2012EP2507235A1 Triazolopyridines
10/10/2012EP2507234A1 Imidazole derivatives as aldosterone synthase inhibitors
10/10/2012EP2507233A1 Substituted triazolopyridines
10/10/2012EP2507232A2 Proline derivatives
10/10/2012EP2507231A1 Indazole derivatives as pi 3 - kinase inhibitors
10/10/2012EP2507229A1 Sulfonamide derivatives as bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
10/10/2012EP2507228A1 Novel spiropiperidine compounds
10/10/2012EP2507227A1 Protein kinase c inhibitors and uses thereof
10/10/2012EP2507226A1 Novel compounds
10/10/2012EP2507225A1 L -dihydro-2-oxoquinoline compounds a 5-ht4 receptor ligands
10/10/2012EP2507223A1 Benzpyrazole derivatives as inhibitors of p13 kinases
10/10/2012EP2507222A1 Salacinol and ponkoranol homologues, derivatives thereof, and methods of synthesizing same
10/10/2012EP2507221A1 Ship1 modulators and methods related thereto
10/10/2012EP2507219A2 Synthesis of syrbactin proteasome inhibitors
10/10/2012EP2507215A1 Diphenyl azepine derivatives as monoamine reuptake inhibitors
10/10/2012EP2506880A1 Compositions comprising nonsteroidal anti - inflammatory drugs
10/10/2012EP2506879A1 Snalp formulations containing antioxidants
10/10/2012EP2506873A2 Vaccine against neoplastic or cancerous lesions caused by human papillomavirus (hpv), procedures, uses and methods
10/10/2012EP2506867A1 Pharmaceutical compositions for the stimulation of stem cells.
10/10/2012EP2506860A1 Dietary fibre composition containing beta-glucan
10/10/2012EP2506859A1 Microspheres of hydrolysed starch with endogenous, charged ligands
10/10/2012EP2506858A1 Starch derivative mixtures
10/10/2012EP2506857A1 Delivery of mrna for the augmentation of proteins and enzymes in human genetic diseases
10/10/2012EP2506856A1 Aminosteroid compounds for topic local application for skin-mucosa decolonisation of staphylococcus aureus
10/10/2012EP2506855A1 Anticancer compounds and screening method
10/10/2012EP2506854A1 Method and composition for treatment and prevention of broad spectrum virus ailments comprising a calcium channel blocker or a calmodulin blocker
10/10/2012EP2506853A1 Combination therapy for treating cancer and diagnostic assays for use therein
10/10/2012EP2506852A2 Interferon therapies in combination with blockade of stat3 activation
10/10/2012EP2506851A1 Use of a dipyridyl compound for treating rosacea
10/10/2012EP2506850A1 Methods of administering pirfenidone therapy
10/10/2012EP2506849A1 Pirfenidone therapy and inducers of cytochrome p450
10/10/2012EP2506848A1 Substances for reducing occurrence of major cardiac events comprising red yeast rice extract and omega-3 polyunsaturated fatty acid or derivative thereof
10/10/2012EP2506847A1 Treatment of infectious diseases
10/10/2012EP2506846A1 Treatment of allodynia and hyperalgesia
10/10/2012EP2506845A1 Combination of droloxifene and clopidogrel
10/10/2012EP2506844A1 Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist
10/10/2012EP2506843A2 Treating xerophthalmia with compounds increasing meibomian gland secretion
10/10/2012EP2506842A2 Formulations, salts and polymorphs of transnorsertraline and uses thereof
10/10/2012EP2506841A1 Topical use of hydroxytyrosol and derivatives for the prevention of hiv infection
10/10/2012EP2506840A1 Uses of hypoxia-inducible factor inhibitors
10/10/2012EP2506838A1 Transdermal testosterone device and delivery
10/10/2012EP2506836A2 Fexofenadine microcapsules and compositions containing them
10/10/2012EP2506831A2 Carboxyvinyl polymer-containing nanoparticle suspension
10/10/2012EP2506814A1 Pharmaceutical composition containing a hypomethylating agent and a histone deacetylase inhibitor
10/10/2012EP2506717A1 Method of using dopamine reuptake inhibitors and their analogs for treating diabetes symptoms and delaying or preventing diabetes-associated pathologic conditions
10/10/2012EP2506716A1 Novel tricyclic compounds
10/10/2012EP2506715A1 Method of treatment of cns disorders
10/10/2012EP2506714A1 Ondansetron orally disintegrating tablet compositions for prevention of nausea and vomiting
10/10/2012EP2506713A1 Novel tricyclic compounds
10/10/2012EP2506712A1 Morphinan derivatives for the treatment of drug overdose
10/10/2012EP2506711A1 Hypersulfated disaccharide formulations
10/10/2012EP2506709A2 Amantadine compositions and methods of use
10/10/2012EP2263654B1 Compositions for improving the oral absorption of antimicrobial agents
10/10/2012EP2213738B1 siRNA molecules targeting Bcl-2
10/10/2012CN1956734B Multi-vitamin and mineral nutritional supplements
10/10/2012CN1953968B Thiazole compound and use thereof
10/10/2012CN1934116B Tricyclic benzopyran compound as anti-arrhythmic agents
10/10/2012CN1880317B Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors
1 ... 1006 1007 1008 1009 1010 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 1023 1024 1025 1026 ... 7860